CardioInsight Technologies
CardioInsight Receives CE Mark, Launches ecVUE in Europe
Having received CE Mark clearance, CardioInsight Technologies has launched its ecVUE System in Europe, and secured its first three clinical customers in England, Germany and France. CardioInsight's patented ecVUE technology gathers electrical information from an electrode "vest" and combines the information with images from a CT scan to produce 3D "electrical maps " of the patient's heart. To date, CardioInsight has completed more than 390 patient studies at leading clinical centers in the United States and Europe across a broad variety of cardiac arrhythmias, as well as CRT for congestive heart failures, demonstrating the unique clinical value of the ecVUE system, the results of which have been published in leading peer-reviewed journals. Learn more at www.cardioinsight.com.
November 30, 2011 | Permalink
CardioInsight Closes $6 Million Funding Round
CardioInsight Technologies has closed a $6 million Series B round of funding with Draper Triangle, Dr. Michel Haissaguerre and company management participating. With the infustion of capital, CardioInsight will accelerate and expand its clinical studies program to include new centers such as the Cleveland Clinic and Penn Medicine Hospital University of PA, as well as to complete the product development program for the first commercial system, targeted for regulatory approval and commercial release in 2011. Learn more about this breakthrough technology at www.cardioinsight.com.
February 9, 2010 | Permalink
CardioInsight Takes its Work to Heart
An article out of Cincinnati highlights CardioInsight Technologies. The Cleveland-based company is working to develop the first non-invasive, real-time, beat-to-beat simultaneous mapping solution for the treatment of cardia arrhythmias and heart failure; the technology takes non-invasive images of the heart's surface. The mapping and localization technology could be critical to ongoing efforts to improve the diagnosis and treatment of heart conditions.
November 19, 2009 | Permalink
CardioInsight Receives Initial Funding
CardioInsight Technologies, Inc., a bioscience start-up based in Cleveland, has closed its first round of funding and is poised to hit the ground running as it works to commercialize the technology known as electrocardiographic imaging. The technology comes out of Case Western Reserve University, in association with University Hospitals of Cleveland. The CardioInsight approach non-invasively images electrical activity on the surface of the heart to diagnose and treat heart problems related to electrical function without performing invasive procedures. Draper Triangle Ventures, JumpStart, Inc. and Case provided the funding.
August 22, 2006 | Permalink
